Publication Cover
Hemoglobin
international journal for hemoglobin research
Volume 8, 1984 - Issue 2
4
Views
1
CrossRef citations to date
0
Altmetric
Original Article

Noncovalent Inhibitors of Sickle Hemoglobin Gelation; Effects of Tetrasubstituted Ammonium Salts

, &
Pages 129-136 | Received 06 Oct 1983, Accepted 13 Jan 1984, Published online: 07 Jul 2009
 

Abstract

The effects of various tetrasubstituted ammonium compounds on the solubility of deoxygenated sickle hemoglobin were evaluated. These conclusions were drawn from the slopes of the solubility profiles obtained: (1) for the homologous series of tetraalkylammonium chloride salts (R4NCl), antigelling potency increased with increasing chain length of the R group: CH3 < C2H5 < C3H7 < C4H9; (2) for halide salts of the tetrabutyl-ammonium cation there was no difference in effectiveness among the anions examined (Br, Cl, F), presumably because of the extremely potent salting-in effect of this cation; (3) substitution of a benzyl for an alkyl group in three tetraalkylammonium chloride salts, C6H5CH2(R)3NCl, where R = CH3, C2H5, or C4H9, potentiated the antigelling capacity by as much as eight-fold. Because they are substantially more water soluble than any other class of noncovalent inhibitors examined to date, further manipulation of the aryl substituent on these compounds may contribute to the design of an effective antisickling agent.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.